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Abstract
Background: We previously identified curcumin as a potent inducer o f fibroblast apoptosis, which could be used to treat 
hypertrophic scar formation. Here we investigated the underlying mechanism o f this process.
Principal Findings: Curcumin-induced apoptosis could not be blocked by caspase-inhibitors and we could not detect any 
caspase-3/7 activity. Curcumin predom inantly induced m itochondria-mediated ROS form ation and stimulated the 
expression o f the redox-sensitive pro-apoptotic factor p53. Inhibition o f the pro-apoptotic signaling enzyme glycogen 
synthase kinase-3ß (GSK-3ß) blocked curcumin-induced apoptosis. Apoptosis was associated w ith high molecular weight 
DNA damage, a possible indicator o f apoptosis-inducing factor (AIF) activity. Indeed, curcumin caused nuclear translocation 
o f AIF, which could be blocked by the antioxidant N-acetyl cysteine. We next investigated how AIF is effluxed from 
mitochondria in more detail. The permeability transition pore complex (PTPC), o f which the voltage-dependent anion 
channel (VDAC) is a component, could be involved since the VDAC-inhibitor DIDS (4,4'-diisothiocyanatostilbene-2,2'- 
disulfonic acid) efficiently blocked AIF translocation. However, PTPC is not involved in AIF release since cyclosporine A, a 
specific inh ib ito r o f the complex did not block apoptosis. Alternatively, the pro-apoptotic protein Bax could have formed 
mitochondrial channels and interacted w ith  VDAC. Curcumin caused mitochondrial translocation o f Bax, which was blocked 
by DIDS, suggesting a Bax-VDAC interaction. Interestingly, ceramide channels can also release apoptogenic factors from 
mitochondria and we found that addition o f ceramide induced caspase-independent apoptosis. Surprisingly, this process 
could also be blocked by DIDS, suggesting the concerted action o f Bax, VDAC and ceramide in the efflux o f AIF from  the 
m itochondrion.
Conclusions: Curcumin-induced fibroblast apoptosis is to ta lly caspase-independent and relies on the mitochondrial 
form ation o f ROS and the subsequent nuclear translocation o f AIF, which is released from a m itochondrial pore that involves 
VDAC, Bax and possibly ceramides. The composition o f the AIF-releasing channel seems to be much more complex than 
previously thought.
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Introduction
We previously demonstrated that a high dose of curcumin 
induces apoptosis in hum an dermal fibroblasts via the formation of 
reactive oxygen species (ROS) [1]. This apoptotic activity of 
curcumin is important, since it may be used to diminish scar 
formation in patients with severe burns. Therefore, we investigated 
the underlying molecular mechanism in more detail.
Apoptosis, also referred to as programmed cell death, is not only 
an im portant mechanism involved in development and homeo­
static regulation but also plays a central role in several pathological 
conditions such as cancer and fibrosis. Generally, apoptosis can 
occur in either a caspase-dependent or -independent fashion. For
caspase-dependent apoptosis two major pathways have been 
identified: the extrinsic pathway, which involves triggering of 
death receptors like tum or necrosis factor (TNF) receptor, FA S/ 
CD95-APO-1 and TRA IL/A PO -2, and the intrinsic pathway in 
which the mitochondrion is the central regulator [2]. Fas- 
associated death domain (FADD) and TNF-receptor-associated 
death domain (TRADD) recruit and activate caspase-8 to form a 
death-inducing signaling complex (DISC) [3]. DISC can propa­
gate the death signal generally in two ways. First, DISC can splice 
Bid, which upon translocation to the mitochondria can cause 
mitochondrial outer membrane permeabilization (MOMP), lead­
ing to the release of pro-apoptotic proteins, such as cytochrome c 
[4]. Cytochrome c can interact with apoptotic protease activating
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factor-1 (Apaf-1) and procaspase 9 to form an apoptosome. This 
complex is able to activate caspase 9, which in turn activates the 
effector caspases 3, 6 and 7, leading to apoptosis [5]. Alternatively, 
DISC can also directly activate these effector caspases [6].
The point-of-no-return for the intrinsic pathway is character­
ized by M OM P, which is controlled by the family of Bcl-2 proteins 
[7]. These proteins are either anti- or pro-apoptotic and the 
balance between these two groups ultimately determines cell 
survival or cell death. The pro-apoptotic Bcl-2 family members 
Bax and Bak probably contribute to M O M P by interacting with 
the Permeability Transition Pore Complex (PTPC), which is 
supposed to consist of the Voltage Dependent Anion Channel 
(VDAC), Cyclophilin D (CypD) and adenine nucleotide translo- 
case (ANT), and allows for the release of cytochrome c from the 
mitochondrial intermembrane space [8,9].
The tum or suppressor p53 is a well known regulator of cell 
division and apoptosis and curcumin has been shown to induce 
apoptosis in a p53-dependent fashion [10]. Importantly, one of the 
mechanisms via which p53 is thought to induce apoptosis is by 
direct activation of Bax [11]. The serine/threonine kinase 
glycogen synthase kinase-3 ß (GSK-3ß) is a multifaceted enzyme 
that has been shown to interact directly with p53 and to promote 
p53-dependent apoptosis thus stimulating the mitochondria- 
mediated intrinsic apoptotic pathway [12,13]. Consequently, 
inhibitors of GSK-3ß offer protection from intrinsic apoptosis.
The mitochondrial release of apoptogenic factors is an 
im portant but poorly understood mechanism. Several of the 
proteins that are released from the mitochondrial intermembrane 
space after M O M P have an anti-apoptotic role e.g. H T R A 2/O m i 
and SM AC/Diablo [14], whereas others are pro-apoptotic, such 
as cytochrome c, apoptosis inducing factor (AIF) and endonuclease 
G (EndoG) [15]. The release of large apoptogenic factors from the 
mitochondria remains controversial, since the pore size of PTPC 
only permits the release of molecules of <13  kDa, like cytochrome 
c [9]. Alternatively, Bax is known to oligomerize and thus form 
pores, called mitochondrial apoptosis-induced channel (MAC), in 
the outer mitochondrial membrane that allows for the release of 
large (>2 MDa) molecules [16,17]. Furthermore, it was recently 
shown that curcumin and other flavonoids induce ceramide 
synthesis and that ceramides have been implicated in apoptosis via 
the formation of channels in the outer mitochondrial membrane, 
which enables the release of large mitochondrial proteins [18-20].
D ata on the exact mitochondrial localization of AIF are 
conflicting. Some studies show that soluble AIF is present in the 
intermembrane space and therefore M O M P alone would be 
sufficient to release this form of AIF from the mitochondria [21]. 
O ther studies postulate that AIF is inserted in the inner 
mitochondrial membrane and therefore needs to be cleaved first, 
by caspases or calpains, followed by M OM P, to efflux from the 
mitochondrion [22]. Following mitochondrial release, AIF trans­
locates to the nucleus via its nuclear localization signal, where it 
contributes to chromatin condensation and high molecular weight 
DNA fragmentation [21]. Furthermore, release of AIF from 
mitochondria triggers another hallmark of apoptosis, the exposure 
of phosphatidylserine (PS) on the extracellular side of the cell 
membrane [21]. The role of EndoG in caspase-independent 
apoptosis is largely unknown but unlike AIF, translocation of 
EndoG to the nucleus results in low molecular weight DNA 
fragmentation, similar to caspase-mediated DNA fragmentation
[23].
We have recently demonstrated that curcumin induced R O S­
mediated apoptosis in dermal fibroblasts, which could be inhibited 
by antioxidant treatm ent or induction of heme oxygenase [1]. 
Here, we aimed to unravel the mechanism underlying this
apoptotic process and we show that curcumin-induced apoptosis 
depends on mitochondrial ROS-formation and the translocation 
of AIF from the mitochondrion to the nucleus and is independent 
of caspase-activity. AIF translocation and subsequent apoptosis 
could be blocked by N-acetyl cysteine and the VDAC-inhibitor 
DIDS, but not by the specific PTPC-inhibitor cyclosporin A. 
Inhibition of VDAC reduced both mitochondrial translocation of 
Bax and ceramide-induced fibroblast apoptosis. Taken together, 
our data shows that the release of apoptogenic factors by curcumin 
from mitochondria involves VDAC, Bax and ceramides, suggest­
ing that the composition of the AIF-releasing channel is possibly 
much more complex than previously thought.
Results
Curcumin-induced apoptosis is not mediated by caspase 
activity
We investigated whether curcumin-induced apoptosis was 
mediated by caspases. Although high levels of pro-caspase-3 were 
detected by Western blot, we were unable to detect the active form 
of caspase-3 protein or a reduction in band intensity of pro- 
caspase-3 after curcumin treatm ent (results not shown). In 
addition, curcumin did not induce caspase-3/7 activity in 
fibroblasts, whereas the apoptosis-inducing agents cisplatin and 
staurosporin increased caspase-activity significantly (both p<0.01, 
figure 1A). Moreover, curcumin-induced apoptosis (25 mM) was 
not blocked by co-incubation with the pan-specific caspase activity 
inhibitor z-FAD-fmk (figure 1B). There was even a significant 
decrease in the percentage of living cells, which was accompanied 
by an increase in early apoptotic cells in the curcumin+z-FAD-fmk 
group, compared to the curcumin group (p<0.001). Treatm ent 
with the caspase-inhibitor alone had no effect on cell viability. 
Absence of caspase activity was confirmed by the finding that 
curcumin treatm ent did not result in internucleosomal low 
molecular weight DNA damage (DNA laddering, results not 
shown).
Curcumin treatment induces Hsp70 expression and 
translocation
Since Hsp70 is an inhibitor of caspase-mediated apoptosis we 
investigated whether its expression was affected by curcumin 
treatment. In unstimulated cells Hsp70 was mainly localized in the 
cytoplasm and some cells showed a spotted pattern in the nucleus 
(Figure 2A). After 24 hours of curcumin-treatment (25 mM) 
fibroblasts showed an increase in Hsp70 expression both in the 
cytoplasm and nucleus (Figure 2B). Quantification of Hsp70 
specific bands on Western blot showed that after curcumin 
treatm ent expression was ~ 4  times higher than in untreated 
controls (Figure 2D). Thus, curcumin induced the expression of 
Hsp70, a protein which is possibly involved in the inhibition of 
caspase activity.
High molecular weight (HMW) DNA fragmentation
Besides internucleosomal caspase-mediated DNA damage, 
H M W  DNA damage has also been described during apoptosis. 
Therefore, we investigated if curcumin treatm ent resulted in 
H M W  DNA damage via single cell DNA electrophoresis (Comet 
assay). Figure 3A clearly shows that curcumin treatm ent resulted 
in a significantly increased comet tail length, which is a direct 
measure for HM W  DNA damage (average tail length of 59 pixels 
in the untreated group vs 138 pixels in the curcumin-treated 
group, p<0.001). Figure B and C are representative pictures of the 
untreated and 25 mM curcumin group, respectively. Curcumin
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A significantly higher than in the untreated situation without FCCP 
(p<0.001), curcumin also seems to induce R O S formation 
independent from mitochondria.
Curcumin induces p53 expression
It is well known that activation of the tum or suppressor p53 can 
induce apoptosis and therefore we studied whether p53 was 
involved in curcumin-induced fibroblast apoptosis. Figure 5A+B 
shows that after 8 hours of curcumin stimulation p53 protein 
expression was increased 4 fold (p<0.05), compared to unstimu­
lated cells. Already after 4 hours and up to 24 hours following 
stimulation with curcumin the expression of p53 was elevated, 
although not statistically significant. Thus, curcumin induces 
protein expression of the proapoptotic factor p53.
Figure 1. Curcumin-Induced Apoptosis is not M ediated by 
Caspase Activity. A). Cells were treated for 24 hours with 25 mM 
curcumin or were left untreated. As a positive control cells were treated 
with 150 mM cisplatin or 2 mM staurosporin. Caspase-3 and -7 activity 
was measured using a fluorescence based commercial assay (see M&M). 
The fluorescence values in the untreated group were set at 100% and 
the other values were normalized accordingly. Shown are the 
mean±SD from 3 independent experiments, * = p<0.05 B). Cells were 
treated with 25 mM curcumin in the presence or absence o f the 
caspase-activity inhibitor z-FAD-fmk (100 mM). Negative controls 
included untreated cells and cells treated only with z-FAD-fmk. After
24 hours, all cells were collected and stained with Annexin-V-FITC and 
propidium iodide and quadrant analysis after flow  cytometry was 
performed. Shown are the mean±SD of the living, early and late 
apoptotic cell fractions from 3 independent experiments, *** = p<0.001 
compared to 25 mM curcumin. 
doi:10.1371/journal.pone.0006688.g001
treatm ent therefore leads to HM W  DNA damage in dermal 
fibroblasts.
ROS assay
We have previously shown that curcumin induces ROS 
formation and that antioxidant treatem ent could fully inhibit 
curcumin-induced apoptosis [1]. Here, we investigated the cellular 
origin of R O S formation. Figure 4 shows that 25 mM curcumin 
significantly induces R O S formation as shown by the increased 
fluorescent signal compared to untreated cells (p<0.001). After 
blocking mitochondrial ROS-production by the protonophore 
FCCP, the fluorescent signal in the curcumin treated cells was 
significantly lowered (p<0.001), indicating that curcumin-induced 
R O S formation is predominantly mediated by mitochondria. 
However, since the signal in the curcumin+FCCP group was still
GSK-3ß inhibitors block curcumin-induced apoptosis
Inhibitors of GSK-3ß can protect cells from apoptosis [13] and it 
has been shown thatp53 is a direct substrate of GSK-3ß activity [12]. 
Therefore, we tested if inhibition of GSK-3ß-activity affected 
curcumin-induced apoptosis. Both pharmacological inhibitors of 
GSK-3ß-activity, lithium and BIO-Acetoxime, were able to signifi­
cantly increase the percentage of living cells to 65% and 72%, 
respectively, compared to 51% in curcumin-treated cells (figure 6A+B, 
both p<0.001). Correspondingly, the percentage of apoptotic cells 
was significantly decreased to 18% and 27% in the groups were GSK- 
3ß was inhibited, compared to 42% after curcumin treatment only 
(both p<0.001, figure 6A+B). These results indicated that GSK-3ß- 
activity mediates curcumin-induced apoptosis.
Curcumin induces translocation of Bax
A well known down-stream target of p53-activity is the pro- 
apoptogenic factor Bax [11,24] and, moreover, Bax has been 
implicated in the formation of mitochondrial channels that are 
involved in the release of apoptogenic proteins. Therefore, we 
studied cellular localization of Bax during curcumin-induced 
apoptosis. Figure 7A-C shows that in the untreated group, Bax 
has a diffuse cytoplasmatic localization outside the mitochondria 
since the mitochondria-specific protein M nSOD did not colocalize 
with Bax. However, after curcumin treatm ent mitochondria 
gathered around the nucleus and Bax was translocated to the 
mitochondria, as indicated by the co-localization with M nSOD 
(figure 7D-F). This showed that curcumin induced the transloca­
tion of the pro-apoptogenic factor Bax to the mitochondria.
Translocation o f Apoptosis Inducing Factor (AIF)
A mechanism to explain HM W  DNA damage and phospha- 
tidylserine flip-flop in a caspase-independent fashion is transloca­
tion of AIF from mitochondria to the nucleus [21,25]. O ur cellular 
fractionation studies showed that after curcumin treatment 
significantly more nuclear AIF was found than in untreated cells 
(p<0.05, figure 8A-B). A specific mitochondrial protein marker 
was shown not to be present in the nucleus after curcumin 
treatment, indicating that the fractionation procedure was not 
confounded by cross contamination (Figure 8C). Furthermore, our 
immunocytochemistry results clearly showed that in untreated 
cells AIF was located in the cytoplasm and not the nucleus 
(figure 8G), whereas after addition of curcumin a time-dependent 
increase of AIF expression in the nucleus was observed, to reach 
maximum levels after 24 hours (figure Figure 8D-F). In line with 
our previously published results the antioxidant N-acetyl cysteine 
was able to completely inhibit AIF translocation (Figure 8H) [1]. 
In conclusion, curcumin causes nuclear translocation of the 
mitochondrial pro-apoptotic factor AIF.
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Figure 2. Curcumin Induces Hsp70 Protein Expression. A-C) Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM 
curcumin or were left untreated. After 24 hours, cells were fixed and permeabilized and subsequently stained using a specific Ab against Hsp70. 
Detection was done via an Alexa-488 labeled secondary Ab. As a negative control the primary Ab was replaced with PolyIgG. A) untreated cells, B)
25 mM curcumin, C) Untreated cells IgG control. D) Cells were treated with 25 mM curcumin or were left untreated. After 24 hours cells were lysed and 
proteins were separated by SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated with Abs against Hsp70 and ß-actin (as a 
loading control) and the appropriate fluorescently labeled secondary Abs. Fluorescence of the specific protein bands was determined using the 
Odyssey Infrared Imaging System. Shown are the mean±SD of the band intensities of Hsp70 corrected for ß-actin from 3 independent experiments, 
*=  p<0.05.
doi:10.1371/journal.pone.0006688.g002
Mitochondrial Inner Membrane Potential
The release of AIF indicated that curcumin rendered the outer 
mitochondrial membrane permeable to proteins. We investigated 
if the permeability of the inner membrane was also affected by 
quantifying mitochondrial accumulation of the mitochondria- 
specific dye TM RE, an indicator of membrane potential loss. 
Figure 9 shows that there was no difference between the 
accumulation of TM R E in mitochondria of curcumin-treated 
cells and untreated cells. As a positive control, we confirmed that 
treatm ent of TM RE-labeled cells with the mitochondrial proto- 
nophore FCCP resulted in a lower fluorescence caused by the 
depolarization of the membrane potential. In unlabelled cells no 
fluorescent signal was observed (Figure 9). Therefore, curcumin 
did not affect the permeability of the inner membrane.
Inhibition o f AIF translocation
Several mechanisms have been described to be involved in the 
release of AIF from mitochondria. O ur results with the pan­
specific caspase-inhibitor rule out a role for caspases in AIF release 
during curcumin-induced fibroblast apoptosis (figure 1B). PARP-
activity is also not involved in the release of AIF since co­
incubation of curcumin with the specific PARP-inhibitor D P Q  did 
not affect curcumin-induced apoptosis (Table 1).
The anion exchanger and channel inhibitor DIDS also inhibits 
the PTPC by blocking VDAC. Figure 10 clearly shows that 
treatm ent with 500 mM DIDS potently blocked curcumin-induced 
apoptosis (Figure 10C+D and I). The percentage of living cells 
significantly increased from 53% in the curcumin-treated group to 
75% in the curcumin+DIDS group (p<0.001), whereas DIDS 
alone had no significant effect on cell survival (Figure 10B+I). 
Correspondingly, the early apoptotic cells decreased significantly 
from 44% in the curcumin group to 22% in the curcumin+DIDS 
group (P<0.01). Next, we investigated whether DIDS provided 
protection by abrogation of curcumin-induced nuclear AIF 
translocation. The data presented in figure 10E-H  confirmed 
that AIF localization in the curcumin+DIDS group was mainly 
cytoplasmic and not nuclear, which was comparable to the 
untreated situation.
To test if DIDS acted through inhibition of chloride channels 
we measured the effect of the specific chloride channel inhibitor
PLoS ONE | www.plosone.org August 2009 | Volume 4 | Issue 8 | e66884
AIF Efflux from Mitochondria
Figure 4. Curcumin-induces ROS form ation. Cells were labelled 
with the ROS-specific labeling dye H2DCFDA before they were treated 
for 45 min with 25 mM curcumin or not treated. To block mitochondrial 
ROS production the uncoupler agent FCCP was used. After treatment, 
cells were lysed and fluorescence was determined at excitation 485 nm 
and emission 520 nm. For each treatment unlabelled cells served as the 
negative control. Shown are the mean±SD o f 3 independent 
experiments. *** = p<0.001, ** = p<0.01 and ###  = p<0.001 compared 
to untreated - FCCP. 
doi:10.1371/journal.pone.0006688.g004
Figure 3. Curcumin Induces HMW  DNA Damage. Cells were 
treated for 72 hours with 25 mM curcumin or were left untreated. HMW 
DNA damage was studied using the CometAssay Reagent kit. Cells were 
resuspended in LMAgarose the mixture was placed on to CometSlides. 
Next, cells were lysed and DNA was released and allowed to unwind. 
After electrophoresis, slides were fixed and nuclei were stained with 
SYBR Green. Positive nuclei were analyzed using a fluorescence 
microscope and a filter for FITC. Nuclei were chosen in a random 
fashion by a blinded observer using a CCD-camera and a computer 
monitor. Comet tail length was quantified by a blinded observer using 
ImageJ image analysis software. A) Shown is a scatter plot were the tail 
length o f the comet o f all positive nuclei in the untreated and 
curcumin-treated group is depicted o f 3 independent experiments. The 
solid horizontal line represents the mean. B) representative picture of a 
nucleus of an untreated cell. C) representative picture of a nucleus of a 
curcumin-treated cell, *** = p<0.001. 
doi:10.1371/journal.pone.0006688.g003
NPPB. Interestingly, NPPB did not rescue cells from curcumin- 
induced apoptosis but rather co-treatment of curcumin with NPPB 
significantly augmented apoptosis from 52% living cells in the 
curcumin group to 32% in the combination group (p<0.01, 
Table 1). These results suggest that chloride channels were not 
involved in the translocation of AIF during curcumin-induced 
apoptosis but that a role for the anion channel VDAC could still 
be possible.
Combined, these data suggest that AIF was released from the 
mitochondrial intermembrane space via the PTPC. To further test 
this possibility we co-treated curcumin-stimulated cells with the 
PTPC inhibitor, cyclosporin A (CsA) [26]. Surprisingly, co­
incubation of CsA and curcumin did not result in a decrease of 
early apoptotic cells compared to curcumin alone, 56% versus 
52% respectively, whereas cisplatin-induced apoptosis was signif­
icantly inhibited by CsA (Table 1). These results rule out the 
PTPC as the AIF releasing pore.
Next, we tested if DIDS affected translocation of Bax, since Bax 
is known to interact with VDAC and create pores in the 
mitochondrial outer membrane. Indeed, treatm ent with curcumin 
in combination with DIDS not only blocked apoptosis and 
perinuclear migration of mitochondria but also prevented Bax 
translocation to the mitochondria (Figure 7G-I), whereas DIDS
Figure 5. Curcumin induces p53 expression. A). Cells were treated 
with 25 mM curcumin for the indicated time points before cells were 
lysed and proteins were separated by SDS-PAGE and blotted onto 
nitrocellulose membranes. Blots were incubated with Abs against p53 
and ß-actin (as a loading control) and the appropriate fluorescently 
labeled secondary Abs. B). Fluorescence o f the specific protein bands 
was determined using the Odyssey Infrared Imaging System. Shown are 
the mean±SD o f the band intensities of Hsp70 corrected for ß-actin 
from 3 independent experiments, * = p<0.05 compared to 0 h. 
doi:10.1371/journal.pone.0006688.g005
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Figure 6. GSK-3|i-inhibitors block curcumin-induced apoptosis.
Cells were treated with 25 mM curcumin in the presence or absence of 
the GSK-3ß activity inhibitors LiCl (A) or BIO-Acetoxime (B). Negative 
controls included untreated cells and cells treated only with z-FAD-fmk. 
After 24 hours, all cells were collected and stained with Annexin-V-FITC 
and propidium iodide and quadrant analysis after flow  cytometry was 
performed. Shown are the mean±SD of the living, early and late 
a p o p to tic  cell frac tions  from  3 independen t experim ents, 
*** = p<0.001, ** = p<0.01 and * = p<0.05 compared to 25 mM 
curcumin.
doi:10.1371/journal.pone.0006688.g006
alone had no effect on AIF localization (Figure 7J-L). Conse­
quently, DIDS blocked curcumin-induced apoptosis, inhibited 
mitochondrial Bax translocation and prevented the release of AIF 
from mitochondria.
Taken together, our results indicate that Bax interacted with 
VDAC to generate a pore that is sensitive to DIDS, insensitive to 
CsA, and permits the efflux of AIF.
Ceramides
Interestingly, curcumin has been shown to induce ceramide 
synthesis and ceramides are able to form pores in mitochondrial 
membranes, thereby allowing for the release of mitochondrial
proteins such as AIF. We decreased ceramide levels by inhibition 
of de novo ceramide synthesis via myriocin and fumonisin. 
However, neither co-incubation of curcumin and the inhibitors 
nor pretreatm ent of the cells with inhibitors prior to curcumin 
treatm ent resulted in inhibition of curcumin-induced apoptosis 
(Table 1). Also, blocking the direct formation of ceramide from 
sphingomyelins by inhibiting sphingomyelinase with manumycin 
did not rescue fibroblasts from curcumin-induced apoptosis 
(Table 1). All substances tested were used at a concentration that 
did not affect cell viability (data not shown). However, we could 
not exclude the possibility that ceramides present in the 
mitochondrial membrane were rearranged after treatm ent with 
curcumin. Therefore, we studied whether exogenously adminis­
tered ceramides could induce fibroblast apoptosis. Figure 11A-D 
shows light microscopic images indicating that 100 mM ceramide 
caused fibroblast apoptosis and, interestingly, co-treatment with 
DIDS resulted in protection, as judged from the considerable 
higher number of attached fibroblast-like cells. Moreover, 
figure 11E, clearly demonstrates that ceramides significantly 
decreased the percentage of living cells, which was accompanied 
by a significant increase in apoptotic cells, compared to untreated 
and DIDS-treated cells (all p<0.001). Furthermore, co-treatment 
of ceramides and DIDS significantly improved the percentage of 
living cells and decreased the percentage of late apoptotic and 
necrotic cells (all p<0.001). The induction of apoptosis by 
ceramides was shown to be independent of caspase-activity 
(Figure 11F). Taken together, we cannot exclude a role for 
ceramides in the formation of pores, possibly in conjunction with 
VDAC and Bax, that allow for the release of AIF from 
mitochondria during curcumin-induced apoptosis.
Discussion
The mechanism by which curcumin induces apoptosis in non­
transformed cells has been linked to both caspase-dependent and -  
independent pathways. In  our model no active caspase-3 or-7 
could be detected and the pan-specific caspase-inhibitor z-FAD- 
fmk did not affect curcumin-induced apoptosis. Piwocka et al. 
previously demonstrated in Jurkat cells that curcumin induced 
caspase-independent apoptosis, which resulted in HM W  DNA 
damage similar to our data, but mitochondria were not involved. 
[27,28]. However, in a later study also in Jurkat cells, the same 
group described that curcumin can also induce apoptosis in a 
caspase-dependent fashion [29]. Similarly, curcumin-induced 
apoptosis in hum an renal Caki cells has been shown to depend 
on R O S formation and caspase activity, since antioxidants and 
caspase inhibitors blocked curcumin-induced DNA fragmentation 
and apoptosis [30]. Recently, it was found in murine fibroblasts 
that curcumin induces both caspase-dependent and caspase- 
independent apoptosis [10]. Similar to our model, in this study 
curcumin stimulated R O S formation, which led to the release of 
AIF from the mitochondria. However, curcumin treatm ent also 
caused release of cytochrome c and the subsequent activation of 
caspase-3 and PARP, which could be blocked by the caspase- 
inhibitor z-FAD-fmk.
In our model no caspase-activity was detected despite high levels 
of pro-caspase-3 protein in both untreated and curcumin-treated 
groups (data not shown), suggesting that the caspase-3-activating 
step was inhibited. Hsp70 is known to inhibit several steps in the 
caspase-dependent apoptosis pathway including apoptosome 
formation and the activation of caspase-8, both of which are 
involved in the activation of caspase-3 [31,32]. It is tempting to 
speculate that the increase in Hsp70 protein expression after 
curcumin treatm ent is involved in the inhibition of the caspase-
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anti-MnSOD
25 nM curcumin
25 nM curcumin + DIDS
IgG controls
Figure 7. Curcumin Induces Bax Translocation. Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM curcumin, 
500 mM DIDS, the combination, or were left untreated. After 24 hours, cells were fixed and permeabilized and subsequently stained using a specific 
Ab against Bax A,D,G,J) and the mitochondrial protein MnSOD B,E,H,K). Detection was done via Alexa-488 for MnSOD (green) and Alexa-594 for Bax 
(red) labeled secondary Ab. C,F,I,L) are overlays o f green and red images. A-C) untreated, D-F) 25 mM curcumin, G-I) 25 mM curcumin+500 mM DIDS, 
J-L) 500 mM DIDS. PolyIgG controls for M) Bax and N) MnSOD. 
doi:10.1371/journal.pone.0006688.g007
dependent pathway in our model, but this needs further 
investigation. O n the other hand, overexpression of Hsp70 has 
also been described to inhibit AIF and Bax translocation [33,34]. 
Obviously, in our apoptosis model the translocation of AIF and 
Bax was not inhibited by increased Hsp70 expression, probably
because in our model the endogenous expression of Hsp70 was 
increased rather than artificially overexpressed by transduction.
We and others have prevously shown that curcumin induces the 
production of R O S and that inhibition of R O S generation 
prevents curcumin-induced apoptosis [1,10]. Here, we investigat-
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Figure 8. Curcumin Induces AIF Translocation to  the Nucleus. A-C) Cells were treated with 25 mM curcumin or were left untreated. After
24 hours cells were lysed and nuclear and cytoplasmatic proteins were isolated using a commercial kit. A) Identical protein concentrations were 
loaded and separated by SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated with Abs against AIF and a mito-marker (as a 
control for protein separation) and the appropriate fluorescently labeled secondary Abs. The fluorescence of the specific protein bands was 
determined using the Odyssey Infrared Imaging System. Shown is the result o f a representative o f 3 independent experiments. B) Mean±SD o f the 
band intensities of AIF from 3 independent experiments. C) Mean±SD of the band intensities of mito-marker from 3 independent experiments. D-I) 
Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM curcumin or were left untreated. After 24 hours, cells were fixed 
and permeabilized and subsequently stained using a specific Ab against AIF. Detection was done via an Alexa-488 labeled secondary Ab. D) 6 hours
25 mM curcumin, E) 16 hours 25 mM curcumin, F) 24 hours 25 mM curcumin, G) untreated cells, H) 24 hours 25 mM curcumin+6 mM NAC, I) 24 hours 
6 mM NAC, * = p<0.05 compared to nuclear AIF in the untreated group.
doi:10.1371/journal.pone.0006688.g008
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Figure 9. Curcumin does not Cause M itochondrial Inner
M em brane Depolarization. Fibroblasts were treated with 25 mM 
curcumin or were left untreated. After 24 hours, cells were labeled for 
30 minutes with 0.1 mM of the fluorescent dye tetramethylrhodamine 
ethyl ester (TMRE), which accumulates in mitochondria. As a negative 
control cells were not labeled. To check if the cells were correctly 
labeled the protonophore FCCP was added, which causes mitochon­
drial membrane depolarization. Fluorescence was determined using 
flow cytometry using channel FL2. Grey peak = untreated cells, thick 
black line = 25 mM curcumin, thin black line = FCCP treatment of 
untreated TMRE-labeled cells, dashed line = unlabelled cells. M1 
represent negatively labeled cells, M2 represents positively labeled cells. 
doi:10.1371/journal.pone.0006688.g009
ed whether the produced R O S were generated in mitochondria or 
had a cytoplasmatic origin. By using the mitochondrial uncoupler 
FCCP, which prevents mitochondrial R O S generation, we 
detected a significantly decreased R O S formation at 25 mM 
curcumin, indicating that mitochondria are predominantly 
involved in curcumin-induced R O S formation. These data 
correspond to previously published results, where lowering the 
bioenergetic capacity of mitochondria suppressed curcumin- 
induced cytotoxicity in hum an cutaneous squamous cell carcino­
ma cells [35]. However, since the levels of R O S in the 
curcumin+FCCP group, were still significantly elevated above 
the level in untreated cells, curcumin also seems to induce 
mitochondria-independent R O S formation.
Apoptosis is often controlled by the redox-sensitive proapoptotic 
factor p53 and curcumin is known to induce p53-dependent 
apoptosis in several cell types [36]. Besides its obvious effects on 
transcription of numerous proapoptotic factors, p53 is also known 
to directly activate Bax, which leads to mitochondrial permeabi- 
lization and subsequent apoptosis [11]. O ur results are in line with 
these data since we show that in dermal fibroblasts curcumin 
induces the expression ofp53, which is followed by mitochondrial 
tranlocation of Bax. Possibly, p53 forms a complex with Bax in the 
mitochondrial membrane as suggested by others [35]. The extend 
of the non-transcriptional activities of p53 in our model is under 
current investigation. The pro-apoptotic signaling enzyme GSK-
Table 1. Effect o f specific inhibitors o f various intracellular 
pathways on curcumin-induced apoptosis.
T re a tm e n t a L iv in g  b Early A p o p to tic  b
m ean6SD m ean6S D
Untreated 9662 4 62
25 mM Curcumin 4069 5768
25 mM Curcumin+30 mM DPQ c 30610 6669
25 mM Curcumin 5265 41 63
25 mM Curcumin+50 mM NPPB d 32 612** 5369*
25 mM Curcumin 4364 5261
25 mM Curcumin+2.5 mM Cyclosporin A e 4069 56614
200 mM Cisplatin 2866 4367
200 mM Cisplatin+2.5 mM Cyclosporin A e 4563** 3262*
25 mM Curcumin 3868 5865
25 mM Curcumin+5 mM Myriocin f 3262 6564
25 mM Curcumin+5 mM Myriocinf (Pre) g 3464 6362
25 mM Curcumin 42614 54611
25 mM Curcumin+100 mM Fumonisin f 39615 56611
25 mM Curcumin+25 mM Fumonisin f (Pre) g 43625 50617
25 mM Curcumin 47613 49610
25 mM Curcumin+100 mM Manumycin f 47614 49611
25 mM Curcumin+100 mM Manumycin f (Pre) g 45614 51 611
aCells were treated for 24 hours as indicated and subsequently stained with 
Annexin-V-FITC and propidium iodide and quadrant analysis after flow  
cytometry was performed.
bShown are the mean % 6standard deviation (SD) from the living and early 
apoptotic cell fractions from 3 independent experiments. 
cDPQ was used as an inhibitor o f PARP activity. 
dNPPB was used as a specific inhibitor o f chloride channels. 
eCyclosporin was used as a specific-inhibitor o f the PTPC.
Inh ib itors o f specific steps in ceramide synthesis.
g''pre'' indicates that the inhib itor was given to the cells 24 hours prior to 
curcumin.
** = p<0.01 a nd * = p<0.05. 
doi:10.1371/journal.pone.0006688.t001
3ß is associated with mitochondria-mediated apoptosis since 
mitochondrial GSK-3ß activity is increased during intrinsic 
apoptosis [36]. Furthermore, it has been shown that GSK-3ß is 
able to bind p53 and that inhibition of GSK-3 activity blocks p53- 
mediated apoptosis [12]. Indeed, in our apoptosis model inhibition 
of GSK-3ß activity by two structurally different inhibitors, rescued 
cells from curcumin-induced apoptosis, which is in line with a 
GSK-3ß - p53 interaction. So, curcumin induces p53 expression, 
which in concert with GSK-3ß, and possibly as one large protein 
complex, causes mitochondrial translocation of Bax.
Although a lot of research on AIF has been performed it still 
remains unclear if it is cleaved from the inner membrane or 
present in a soluble form in the intermembrane space. (ADP- 
ribose) polymerase-1 (PARP) activity has been shown to be an 
im portant activator of caspase-independent apoptosis and involved 
in the release of AIF, which eventually leads to high molecular 
weight DNA fragmentation, M O M P and the release of cyto­
chrome c [37]. But in our hands inhibition of PARP activity by its 
specific inhibitor D P Q d id  not block curcumin-induced apoptosis, 
indicating that PARP activity did not play a role in the release of 
AIF. Alternatively, it is often assumed that caspase activity is 
essential for cleaving AIF from the inner mitochondrial mem­
brane, causing the protein to become soluble in the intermem-
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Figure 10. DIDS Inhibits Curcumin-Induced Fibroblast Apoptosis and AIF Translocation to  the Nucleus. Cells were seeded on diagnostic 
microscope slides and treated with 25 mM curcumin, 500 mM DIDS, the combination, or were left untreated. A-D) Cell morphology after 24 hours of 
treatment. E-H) Immunocytochemistry o f AIF. Cells were fixed and permeabilized and subsequently stained using a specific Ab against AIF. Detection 
was done via an Alexa-488 labeled secondary Ab. A+E) untreated, B+F) 500 mM DIDS, C+G) 25 mM curcumin, D+H) 25 mM curcumin+500 mM DIDS. I) 
Flow cytometry data. Cells were collected and stained with Annexin-V-FITC and propidium iodide and quadrant analysis after flow cytometry was 
performed. Shown are the mean6SD from the living, early and late apoptotic cell fractions from 3 independent experiments, *** = p<0.001 and 
** = p<0.01 compared to 25 mM curcumin. 
doi:10.1371/journal.pone.0006688.g010
brane space [38-40]. In line with our data, others have reported 
that in the presence of the pan-specific caspase inhibitor z-FAD- 
fmk, AIF is still able to translocate to the nucleus, which argues 
against a role for caspases in the release of AIF [21,37]. Calpains 
are also thought to cleave AIF from the inner membrane [22] but 
since z-FAD-fmk is known to inhibit calpain activity it is likely that 
in our model curcumin-induced apoptosis relies on soluble AIF 
present in the mitochondrial intermembrane space.
DIDS is a non-selective inhibitor of anion exchangers and 
channels and it can prevent apoptosis by a yet unknown 
mechanism. DIDS has been described to inhibit apoptosis via 
prevention of cell volume decrease by blocking volume sensitive 
outwardly rectifying (VSOR) channels. However, in our flow 
cytometry studies curcumin-treatment did not change the forward 
scatter of cells, indicating that cell size was unaltered (data not 
shown). Another likely target for DIDS in the inhibition of
apoptosis is VDAC, which is located in the outer mitochondrial 
membrane. It was recently reported that DIDS prevented 
cisplatin-induced cell death by inhibiting conformational activa­
tion of Bax, which was shown to depend on VDAC [41]. In 
another recent study, DIDS attenuated staurosporin-induced 
apoptosis in cardiomyocytes partly by preventing the translocation 
of Bax, similar to our findings, but in this study apoptosis was 
mediated by cytochrome c and caspase activity and not by AIF 
[42]. How DIDS influences the release of mitochondrial proteins 
requires further investigation.
The release of large apoptogenic proteins from the mitochon­
drial intermembrane space during apoptosis remains controversial. 
The PTPC consists of the anion channel VDAC, ANT and CypD 
and has long been implicated in this process but its pore size is too 
small to allow passage of AIF [43]. Since we observed no change 
in membrane potential after curcumin stimulation, ANT, which is
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Figure 11. Ceram ide Induces Caspase-Independent Fibroblast Apoptosis. Cells were seeded and treated with 100 mM ceramide, 500 mM 
DIDS, the combination, or were left untreated. A-D) Cell morphology after 24 hours o f treatment. E) Flow cytometry data. Cells were collected and 
stained with Annexin-V-FITC and propidium iodide and quadrant analysis after flow cytometry was performed. Shown are the mean6SD from the 
living, early and late apoptotic cell fractions from 3 independent experiments. F) Caspase-3 and -7 activity were measured using a fluorescence based 
commercial assay. The fluorescence values in the untreated group were stated as 100% and the other values were normalized accordingly. Shown are 
the mean6SD from 3 independent experiments, * = p<0.05 *** = p<0.001 and ** = p<0.01 compared to 100 mM ceramide. 
doi:10.1371/journal.pone.0006688.g011
located in the inner mitochondrial membrane, could not be 
involved. Also the potent and specific CypD-inhibitor CsA had no 
effect on curcumin-induced apoptosis, further ruling out the 
involvement of the PTPC. The pro-apoptotic protein Bax can 
interact with VDAC and has been shown to be essential for the 
release of AIF [8,22]. However, the pores formed by this 
interaction are only permeable to proteins of ~ 1 3  kDa like 
cytochrome c and not the much larger AIF protein (57 kDA) [9]. 
Bax by itself can also oligomerize and form supramolecular 
openings that would allow for the release of AIF [17,44]. The 
strong rescuing effect of DIDS on curcumin-induced apoptosis as 
observed in this study, however, makes it hard to envision a 
channel without a role for VDAC. It is intriguing how DIDS, a 
drug thought to act on mitochondrial VDAC, prevents the 
translocation of Bax from cytoplasm to mitochondria. DIDS 
perhaps binds to VDAC, which is thought to act as an anchor 
point, in such a way that the interaction with Bax is hindered. On 
the other hand, inhibition of VDAC by DIDS could block an as 
yet unknown signal originating from mitochondria, which triggers 
Bax translocation.
Curcumin and other flavonoids increase ceramide levels and 
ceramides are known to induce apoptosis [19,20]. Combined with 
the fact that ceramides can generate large pores in mitochondrial 
membranes [45,46], this led us to investigate whether ceramides 
could play a role in curcumin-induced apoptosis. Inhibition of de
novo synthesis and inhibition of the ceramide-generating enzyme 
sphingomyelinases did not significantly block curcumin-induced 
apoptosis, indicating that ceramides either are not involved or are 
sufficiently present in mitochondrial membranes. The addition of 
exogenous ceramides indeed resulted in fibroblast apoptosis and, 
strikingly, this form of apoptosis was not only independent of 
caspase-activity but could also be inhibited by DIDS in a similar 
fashion as curcumin-induced apoptosis, therefore signifying a role 
for VDAC in ceramide-induced apoptosis. These data are 
suggestive for a concerted action of ceramides, VDAC and 
possibly Bax in the formation of channels in the outer 
mitochondrial membranes to release AIF.
The mechanism via which curcumin induces apoptosis seems to 
be complex and dependent on the cell type studied and caspase- 
activity may be a confounding factor in the identification of the 
exact mechanism how apoptogenic factors are released from 
mitochondria. We show in our model that curcumin induces 
predominantly the formation of mitochondria-mediated ROS. 
Curcumin-induced apoptosis is totally independent from caspase- 
activity, and, more specifically, relies on AIF release, since we 
observed nuclear translocation of AIF and H M W  DNA damage. 
Inhibition of AIF translocation also blocked curcumin-induced 
apoptosis. In our attempt to identify via which mechanism AIF is 
released from mitochondria after curcumin stimulation we 
gathered evidence that not only VDAC and Bax, but also
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ceramides, are involved in the formation of a channel that permits 
the release of large proteins such as AIF from the mitochondrial 
intermembrane space. The unique caspase-independent apoptosis 
model described here can give im portant clues to further research 
on how apoptogenic factors are released from mitochondria.
Materials and Methods
Fibroblast culture
H um an foreskin-derived fibroblasts were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) with high glucose, containing 
10% fetal calf serum (MP Biomedicals, Uden, the Netherlands) 
and 1% penicillin/streptomycin/amphotericin B (Invitrogen life 
sciences, Breda, the Netherlands) at 37°C in an 5% C O 2 
atmosphere. Medium was refreshed every 2-3 days and when 
the cells reached ~90%  confluence they were subcultured using 
trypsin-EDTA (Invitrogen) at a 1:3 dilution.
Western blotting
Cleavage of caspase-3, expression levels of Hsp70, p53 and the 
subcellular localization of AIF was investigated by Western 
blotting after 25 mM curcumin treatm ent and compared to 
untreated cells. Subcellular localization of AIF was studied using 
the NE-PER Nuclear and Cytoplasmic Extraction Reagent 
(Pierce, Thermo Fisher Scientific, Etten-Leur, The Netherlands) 
according to manufacturers protocol. SDS-Page and Western 
blotting procedure were essentially performed as described 
previously [1]. Blots were incubated for 1 hour at R T  with mouse 
anti-caspase-3 Ab (1:500; eBiosciences, AMDS Benelux, Malden, 
The Netherlands), rabbit anti-Hsp70 (Koma Biotech Inc. via 
Abcam), mouse anti-p53 (1:2500; BD Biosciences, Breda, The 
Netherlands) or rabbit anti-AIF Ab (1:1000, Millipore, Amster­
dam, The Netherlands). Rabbit-anti-ß-actin Ab served as a protein 
loading control (1:1000, Abcam, Cambridge, UK). The quality of 
cell fractionation was verified by staining for a mitochondria- 
specific protein (1:500, mouse anti-mito-marker, Abcam). The 
secondary antibodies used were, goat-anti-mouse Alexa Fluor 680 
(1:20.000, Rockland, Heerhugowaard, the Netherlands) and goat- 
anti-rabbit IRDye 800 (1:20.000 Sigma-Aldrich, Zwijndrecht, The 
Netherlands). The membranes were scanned using the Odyssey 
Infrared Imaging System (LI-COR Biosciences, Westburg B.V., 
Leusden, The Netherlands).
Caspase-3/7 activity assay
Fibroblasts were seeded in a 96-well plate and treated for 
48 hours with different doses of curcumin, ceramide or as a 
positive control with cisplatin and staurosporin, or were left 
untreated (negative control). Caspase-3/7 activity was determined 
by the Apo-ONE Caspase-3/7 Assay (Promega, Leiden, The 
Netherlands) according to the manufacturers recommendations. 
Formation of the fluorescent product of caspase activity was 
measured using a Polarstar Galaxy plate reader (BMG Lab­
Technologies GmbH, Offenburg, Germany).
Comet assay
H M W  DNA damage was studied using the CometAssay 
Reagent kit (Trevigen, SanBio b.v., Uden, The Netherlands). 
Fibroblasts were plated at 70% confluence in 6-well plates and 
allowed to adhere for at least 6 hours before the cells were treated 
with varying doses of curcumin for 72 hours. Cells were released 
by trypsin and 10,000 cells were resuspended in 75 ml LMAgarose 
and subsequently the agarose-cell mixture was placed on to 
CometSlides. After incubating the slides for 30 min at 4°C to let 
the agarose solidify, the slides were incubated for 60 min in lysis
buffer at 4°C to lyse the cells and release DNA. Next, slides were 
transferred to a horizontal electrophoresis tray (Owl separation 
system) filled with an alkaline electrophoresis buffer (300 mM 
N aO H , 1 mM  EDTA, p H >  13) and DNA was allowed to unwind 
during 30 min at 4°C. Electrophoresis was carried out at 25 V  for 
30 min at 4°C, after which the slides were washed three times with 
neutralization buffer (0.4 M  Tris-HCl, pH  7.5). CometSlides were 
fixed with 100% ethanol for 10 min, air dried and DNA was 
visualized using SYBR Green I solution (1:10,000 dilution in TE 
buffer, 5 min at 4°C). SYBR Green positive nuclei were analyzed 
using a fluorescence microscope (Leica D M  RA) using a filter for 
fluorescein isothiocyanate (FITC). Per treatm ent 38 nuclei were 
chosen in a random fashion by a blinded observer using a Cohu 
high-performance charge-coupled device camera and a computer 
monitor. Comet tail length was quantified by a blinded observer 
using ImageJ image analysis software (National Institutes of 
Health, Bethesda, Maryland, USA, http ://rsb .info .n ih .gov/ij/).
Measurement o f Reactive Oxygen Species (ROS)
RO S formation induced by curcumin was determined as 
described previously [1]. In brief, the ROS-specific labeling dye 
5-(and-6)-chloromethyl-2,,7'-dichlorodihydrofluorescein diacetate, 
acetyl ester (H2DCFDA, Invitrogen) was used to label the cells 
(10 mM H 2DCFDA in Hanks’ Balanced Salt Solution (HBSS) for
15 min at 37°C). Subsequently, cells were washed once with 
HBSS and treated for 45 min with 25 mM curcumin or not 
treated. To study whether curcumin induced cytoplasmatic or 
mitochondrial R O S production, we used the uncoupler agent 
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, In- 
vitrogen), which disrupts A TP synthesis and hence mitochondrial 
RO S production. Cells were pretreated for 10 min with 1 mM 
FCCP prior to labeling with H 2DCFDA and also during the 
labeling and treatm ent steps 1 mM FCCP was present. Afterwards, 
cells were washed with HBSS and fluorescence was determined 
using a Fluostar Galaxy fluorometer at excitation 485 nm and 
emission 520 nm (BMG Lab Technologies, Offenburg, Germany). 
For each treatm ent unlabelled cells served as the negative control.
Determination o f Mitochondrial Membrane Potential
To investigate if curcumin induced loss of inner mitochondrial 
membrane potential we determined mitochondrial accumulation 
of the fluorescent dye tetramethylrhodamine ethyl ester (TMRE, 
Invitrogen) in curcumin-treated and untreated fibroblasts. To 
check if the cells were correctly labeled the mitochondrial 
protonophore FCCP (p-trifluoromethoxy carbonyl cyanide phenyl 
hydrazone, Invitrogen) was added, which induces mitochondrial 
membrane depolarization. As a negative control, cells were not 
labeled. After treatm ent cells were collected and labeled for 
30 minutes with 0.1 mM TM R E (Invitrogen). Next, cells were 
washed with PBS and fluorescence was determined using flow 
cytometry (FACScan, BD Biosciences) using channel FL2.
Modulation o f curcumin-induced apoptosis
We investigated which factors are involved in curcumin-induced 
apoptosis. To test whether caspases are involved in mitochondrial 
release of AIF during curcumin-induced apoptosis, fibroblasts were 
treated with 25 mM curcumin in the presence or absence of the pan­
specific caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoro- 
methylketone (z-VAD-fmk, 100 mM, R&D Systems, Abingdon, 
UK). LiCl (80 mM, Sigma-Aldrich) and BIO-Acetoxime (2 mM, 
Calbiochem, San Diego, CA, USA) were used to study their 
inhibitory effect on GSK-3ß-activity. The specific inhibitor D P Q  
(3,4-Dihydro-5- [4-(1-piperidinyl)butoxyl] -1 (2H)-isoquinolinone, Sig- 
ma-Aldrich, 30 mM) was used to block PARP-activity. The effect of
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the anion channel blocker DIDS ^^'-diisothiocyanatostilbene^^'- 
disulfonic acid disodium salt hydrate, Sigma-Aldrich, 500 mM) and 
the specific chloride channel inhibitor NPPB (nitro -2 -(4- 
phenylpropylamino) benzoic acid, Sigma-Aldrich, 50-100 mM) on 
curcumin-induced apoptosis was also studied. The effect of blocking 
ceramide generation on curcumin-induced apoptosis was studied by 
blocking de novo synthesis of ceramide by pretreating the cells for 24­
48 hours before exposure to curcumin with different doses of 
myriocin (Sigma-Aldrich, 5-50 mM) or fumonisin (Sigma-Aldrich, 
50-100 mM). Direct generation of ceramide from sphingomyelins by 
sphingomyelinase during curcumin-induced apoptosis was blocked 
by addition of different doses of manumycin (Sigma-Aldrich, 1­
10 mM). Ceramides (Sigma-Aldrich) were added in a concentration 
of 100 mM to fibroblasts to check if apoptosis was induced in the 
presence or absence of 500 mM DIDS. Cyclosporin A (CsA, Sigma- 
Aldrich) in a concentration of 2.5 mM was used as a blocker of the 
PTPC to test if this channel was involved in curcumin-induced 
apoptosis. All tested inhibitors were used at a concentration that did 
not affect cell viability. Apoptosis was investigated by flow cytometry 
(see below). Fibroblasts were plated at 70% confluence in 6-well plates 
for FACS analysis or for immunocytochemistry purposes on 12-well 
diagnostic microscope slides (Cel-Line, Thermo Scientific, Braunsch­
weig, Germany) and allowed to adhere for at least 6 hours before cells 
were treated.
Flow cytometry
Flow cytometry analysis was used to differentiate between living, 
early apoptotic, late apoptotic/necrotic and necrotic cells by 
staining with Annexin V-FITC and propidium iodide (PI). After 
48 hours of treatment, all cells were collected and 100,000 cells 
were resuspended in 100 ml binding buffer containing Annexin V- 
FITC and PI according to the manufacturers recommendations 
(BioVision Inc, IT K  Diagnostics b.v., Uithoorn, The Netherlands). 
Next, samples were incubated for 15 min. at R T  in the dark. As a 
positive control for the Annexin V-FITC and PI staining, 
fibroblasts fixed with 4% paraformaldehyde and permeabilized 
by 0.1% saponine were used. Quantification of Annexin V-FITC 
and PI binding was performed by a FACScan (BD Biosciences) 
using channels FL-1 (Annexin V-FITC) and FL-3 (PI). Cellquest 
Pro was used to perform quadrant analysis.
Immunocytochemistry
To study cellular localization of AIF, Hsp70, manganese 
superoxide dismutase (MnSOD, mitochondrial marker) and Bax
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we used immunocytochemistry. After 24 hours of treatment, cells 
were washed with PBS and fixed for 15 min in 4% paraformal­
dehyde in PBS. Next, the cells were washed three times and cells 
were permeabilized and aspecific epitopes were blocked for 
30 min at R T  with PBA (1% bovine serum albumin, 0.1% 
saponin, 0.05% N aN 3 in PBS) together with 2% serum of the 
animal species in which the secondary antibody was generated. 
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(Abcam) were incubated for 45 min in PBA at a concentration of
5 mg/ml or as indicated by the manufacturer. As a negative 
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using a fluorescence microscope (Leica D M  RA) using a filter for 
tetramethyl rhodamine iso-thiocyanate (TRITC) an d /o r FITC. 
Images were taken via a Cohu high-performance charge-coupled 
device camera and a computer monitor.
Statistical analysis
Statistics were performed using GraphPad Prism 4.03 software 
via a One-way analysis of variance (ANOVA) followed by the 
Newman-Keuls multiple comparison test when comparing 3 or 
more groups. A Student’s T-test was used when comparing 2 
groups. Differences between groups were stated to be statistically 
significant when p<0.05. All experiments were repeated at least 3 
times.
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